MetaCap

electroCore (ECOR) vs Vivani Medical (VANI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

electroCore (ECOR) has outperformed Vivani Medical (VANI) over the past year, losing 6.2% versus a loss of 13.6%. Over five years, ECOR leads with a -61.2% price change compared with -81.8% for VANI. Vivani Medical is the larger company by market cap ($102.8 million vs $40.8 million), about 2.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ECOR-6.16%VANI-13.64%
+170%+66%-38%
Nov 21, 20251 yearNov 20, 2026
ECOR-61.13%VANI-83.76%
+63%-16%-95%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ECOR versus VANI key metrics
MetricECORVANI
Share price$4.42$1.14
Market cap$40.78M$102.83M
1-day change-8.87%+4.59%
YTD return-1.45%-7.32%
1-year return-6.16%-13.64%
5-year return-61.23%-81.82%
EPS (TTM)$-1.36$-0.33
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$32.03M$0
Revenue growth (YoY)+27.20%—
Net income (latest FY)$-13.97M$-26.61M
Gross margin86.75%—
Operating margin-41.06%—
Net margin-43.60%—
52-week high$12.70$1.66
52-week low$3.90$0.80
Distance from 52-week high-65.20%-31.37%
Analyst consensusnonestrong_buy
Avg. price target upside+333.71%+235.96%
Average volume120.32K228.83K
Shares outstanding9.23M90.20M
Employees8342
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Vivani Medical is about 2.5 times larger than electroCore by market value ($102.83M vs $40.78M).

About electroCore

ECOR stock →

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 83 employees

About Vivani Medical

VANI stock →

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees

ECOR vs VANI FAQ

Which is bigger, electroCore or Vivani Medical?

Vivani Medical (VANI) is larger, with a market capitalization of $102.83M compared with $40.78M for electroCore (ECOR).

Which stock has performed better over the past year, ECOR or VANI?

ECOR returned -6.16% over the past 12 months, compared with -13.64% for VANI (price return, excluding dividends). Past performance does not predict future results.

Are electroCore and Vivani Medical in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons